Italy Cardiac Surgery Instruments Market Report 2022 to 2030

Italy Cardiac Surgery Instruments Market Analysis

$ 3999

Italy's Cardiac Surgery Instruments Market is expected to witness growth from $50 Mn in 2022 to $80 Mn in 2030 with a CAGR of 6.10% for the forecasted year 2022-30. Ambulatory surgical facilities are becoming more popular in Italy due to their benefits, which include lower expenses, shorter hospital stays, and quicker recovery times. The need for specialized cardiac surgery instruments has grown because ambulatory surgical centers need them to perform procedures, which leads to a growth of the market for these instruments in the Italian healthcare sector. The market is segmented by type, application, and end user. Some key players in this market include Progetti Srl, Esaote SpA, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.

ID: IN10ITMD004 CATEGORY: Medical Devices GEOGRAPHY: Italy AUTHOR: Jigyasu Bhandari

Buy Now

Italy Cardiac Surgery Instruments Healthcare Market Executive Analysis

Italy's Cardiac Surgery Instruments Market is expected to witness growth from $50 Mn in 2022 to $80 Mn in 2030 with a CAGR of 6.10% for the forecasted year 2022-30. The healthcare cost as a percentage of GDP in Italy is 8.67%, and the average annual healthcare price is $2,906 there. Italy's health expenditures in 2020 were roughly 74% publicly funded, which is a smaller proportion than the 80% average for the EU. The Italian government raised the amount it spent on the healthcare system by 3.3% in 2020 and 1.7% in 2021, or an additional $3.85 billion and $1.9 billion, respectively.

In Italy, the leading causes of death are Cardiovascular Diseases (CVDs), which account for about 37% of all deaths. The two most common CVDs in Italy are ischemic heart disease and hypertensive heart disease. Cardiovascular Disease is the leading source of mortality in Italy. (CVD). Cardiovascular illness is the main cause of death in Italy, accounting for 45% of all deaths. Hypertension, or high blood pressure, is a major CVD risk factor. In Italy, hypertension affects about one in three individuals. When the heart does not receive enough blood and oxygen, ischemic heart disease, a common form of CVD in Italy with an age-standardized prevalence of 4.7%, develops.

Instruments for cardiac surgery are specialized medical devices that are used in a range of cardiac surgical operations. These tools are essential for assuring the effectiveness and safety of these surgeries. As a form of cardiac surgery, open-heart surgery entails cutting open the chest to operate on the heart. Open-heart surgery operations like Coronary Artery Bypass Grafting (CABG), valve replacement, and repair are all carried out using cardiac surgery tools. Smaller incisions and specialized instruments are used in minimally invasive surgery, a sort of cardiac surgery. The use of cardiac surgery tools in minimally invasive procedures enables doctors to perform procedures through smaller incisions, lowering the risk of infection, bleeding, and pain while hastening patient recovery. Cardiac surgery tools are made to give doctors the accuracy and precision they need to carry out challenging heart surgeries. These tools give doctors the control and precision they need to carry out complex operations like suturing, cutting, and dissecting, which benefits patients.

Italy Cardiac Surgery Instruments Market Analysis

Market Dynamics

Market Growth Drivers

In Italy, ambulatory surgical facilities are becoming more popular due to their benefits, which include lower expenses, shorter hospital stays, and quicker recovery times. The need for specialized cardiac surgery instruments has grown because ambulatory surgical centres need them to perform procedures, which leads to a growth of the market for these instruments in the Italian healthcare sector. The frequency and incidence of cardiac diseases are rising in Italy, which is driving up demand for cardiac surgery operations and related equipment. Minimally invasive cardiac surgeries, requiring specialist equipment, are becoming more popular in Italy. The market for cardiac surgery instruments is growing in the Italian healthcare industry as a result of minimally invasive procedures' shorter recovery times, decreased chance of complications, and better patient outcomes. Italy has a developed healthcare infrastructure with significant healthcare spending. The market for cardiac surgery instruments is expanding as a result of rising healthcare spending and healthcare providers' investments in cutting-edge medical equipment and technologies to better patient outcomes.

Market Restraints

In Italy, many well-known firms are vying for market supremacy in the fiercely competitive Italian market for cardiac surgery instruments. Newcomers to the market may struggle to obtain traction in contrast to well-established brands with strong reputations and established customer bases. The stringent regulatory requirements that apply to the market for cardiac surgery instruments in Italy have the potential to slow down the clearance and commercialization process for novel devices. Making sure that the instruments meet the necessary performance and safety standards can be a time-consuming and costly process for manufacturers.

Competitive Landscape

Key Players

Progetti Srl (IT)
Esaote SpA (IT)
LivaNova
B. Braun
KLS Martin
Medline Industries
STILLE

Healthcare Policies and Regulatory Landscape

In Italy, cardiac surgery instruments are governed by the Italian Ministry of Health and the Italian Medicines Agency (AIFA). Medical devices are categorized according to the amount of danger they pose to patients, and different regulatory oversight levels are then applied in accordance. The regulatory framework for cardiac surgery instruments in Italy is governed by EU rules that have been integrated into national law. These regulations specify the requirements for the design, evaluation, approval, production, and sale of medical devices. Enhancing patient protection and fortifying the medical device regulatory framework, Italy has adopted the Medical Devices Regulation (MDR) and In Vitro Diagnostic Medical Devices Regulation (IVDR). The MDR and IVDR apply stricter rules for clinical evidence, post-market surveillance, and the evaluation of the safety and performance of medical devices.

1. Executive Summary
1.1 Device Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Regulatory Landscape for Medical Device
1.6 Health Insurance Coverage in Country
1.7 Type of Medical Device
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiac Surgery Instruments Market Segmentation

By Type (Revenue, USD Billion):

The market is divided into segments in this study based on the goods, applications, end users, and geographical areas. The market is divided into forceps, scissors, needle holders, clamps, and other cardiac surgery instruments based on the product. In 2017 the forceps category led the market, and it is anticipated that it will increase at the fastest rate going forward. The rise in heart surgeries and the frequent usage of forceps in most cardiac procedures are credited with the segment's strong growth.

Forceps
Vascular Forceps
Grasping Forceps
Other Forceps
Needle Holders
Scissors
Clamps
Other Cardiac Surgical Instruments

By Application (Revenue, USD Billion):

The market is further segmented by application into paediatric cardiac surgery, heart valve surgery, coronary artery bypass graft (CABG), and other applications. The Itlay market's largest and fastest-growing application segment is CABG. This is mostly explained by the increased prevalence of heart illnesses and the consequent rise in surgical treatments. The second-largest category is heart valve surgery.

Coronary Artery Bypass Graft (CABG)
Heart Valve Surgery
Pediatric Cardiac Surgery
Other Applications

By End User (Revenue, USD Billion):

Based on the end user, the market is segmented into hospitals and cardiac centers, and ambulatory surgery centers. The hospitals and cardiac centers segment is expected to dominate the market for cardiac surgery instruments. Growth in this end-user segment can be attributed to the increasing incidence of cardiac and heart valve diseases and the subsequent increase in the number of cardiac surgery procedures.

Hospitals and Cardiac Centers
Ambulatory Surgery Centers

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.